Investors

Insider Transactions

Date Sorted Ascending Name Title Type Shares Traded Price Range
Oct 1, 2007 vagelos p roy Director Automatic Sell 11,560 n/a
Oct 2, 2007 shooter eric m Director Option Execute 10,000 7.66
Oct 2, 2007 shooter eric m Director Sell 10,000 18.30 - 18.37
Nov 2, 2007 mccorkle douglas s Officer Option Execute 6,209 8.50 - 9.49
Nov 2, 2007 mccorkle douglas s Officer Automatic Sell 6,209 21.00 - 21.03
Nov 5, 2007 brown michael s Director Automatic Sell 600 20.67 - 20.87
Nov 5, 2007 brown michael s Director Option Execute 10,000 7.91
Nov 5, 2007 brown michael s Director Automatic Sell 13,292 20.31 - 20.66
Nov 5, 2007 goldstein joseph l Director Option Execute 800 7.66
Nov 5, 2007 goldstein joseph l Director Automatic Sell 800 20.64 - 20.87
Nov 5, 2007 goldstein joseph l Director Option Execute 4,200 7.66
Nov 5, 2007 goldstein joseph l Director Automatic Sell 4,200 20.38 - 20.63
Nov 6, 2007 brown michael s Director Automatic Sell 6,108 19.42 - 20.08
Nov 20, 2007 roberts william Officer Acquisition (Non Open Market) 34,684 n/a
Nov 20, 2007 vagelos p roy Director Automatic Sell 138,737 n/a
Dec 12, 2007 gilman alfred g Director Disposition (Non Open Market) 2,000 n/a
Dec 17, 2007 gilman alfred g Director Disposition (Non Open Market) 1,500 n/a
Dec 17, 2007 goldberg murray a Officer Disposition (Non Open Market) 200 n/a
Dec 17, 2007 yancopoulos george Officer Acquisition (Non Open Market) 500,000 n/a
Dec 19, 2007 gilman alfred g Director Disposition (Non Open Market) 500 n/a
Showing 1-20 of 840 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42  See Next 20

Stock transaction information provided by EDGAR Online. Regeneron Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.



Close
Form content here please :)